3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Lymphoma, Extranodal NK-T-Cell
2
TMB-H
1
Recurrence
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Cholangiocarcinoma
1
Biliary Tract Neoplasms
1
Interventions
IMC-001
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
TMB-H
×
IMC-001
×
Clear all
NCT06365840
2026-04-17
TMB-H
ImmuneOncia Therapeutics Inc.
Phase 2
Recruiting
30 enrolled